Discovering Hong Kong's Undiscovered Gems In August 2024

In This Article:

As global markets navigate volatility and mixed economic signals, the Hong Kong market has shown resilience, with the Hang Seng Index gaining 0.85% amidst broader concerns about deflationary pressures in China. This backdrop presents a unique opportunity to explore lesser-known stocks that could offer potential growth despite uncertain times. In such an environment, identifying promising stocks involves looking for companies with strong fundamentals and solid growth prospects that can withstand market fluctuations.

Top 10 Undiscovered Gems With Strong Fundamentals In Hong Kong

Name

Debt To Equity

Revenue Growth

Earnings Growth

Health Rating

E-Commodities Holdings

23.22%

6.87%

31.81%

★★★★★★

PW Medtech Group

NA

17.93%

-2.70%

★★★★★★

China Leon Inspection Holding

17.06%

24.06%

27.08%

★★★★★★

Tianyun International Holdings

10.09%

-5.59%

-9.92%

★★★★★★

JiaXing Gas Group

17.72%

26.04%

22.07%

★★★★★☆

Xin Point Holdings

2.03%

9.80%

15.04%

★★★★★☆

Hung Hing Printing Group

3.97%

-2.51%

33.57%

★★★★★☆

Changjiu Holdings

14.09%

12.87%

-4.74%

★★★★★☆

Time Interconnect Technology

212.50%

27.21%

15.01%

★★★★☆☆

Pizu Group Holdings

48.34%

-4.53%

-19.78%

★★★★☆☆

Click here to see the full list of 175 stocks from our SEHK Undiscovered Gems With Strong Fundamentals screener.

Let's explore several standout options from the results in the screener.

YiChang HEC ChangJiang Pharmaceutical

Simply Wall St Value Rating: ★★★★★☆

Overview: YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (SEHK:1558) focuses on the research, development, manufacturing, and sale of pharmaceutical products with a market cap of approximately HK$8.61 billion.

Operations: YiChang HEC ChangJiang Pharmaceutical generates revenue primarily from the sales of pharmaceutical products, amounting to CN¥6.29 billion. The net profit margin for the company is 16.50%.

YiChang HEC ChangJiang Pharmaceutical, a notable player in the Hong Kong market, has demonstrated robust financial health with a net debt to equity ratio of 9.2%, which is considered satisfactory. The company's interest payments are well covered by EBIT at 16.9x coverage, indicating strong profitability. Its price-to-earnings ratio stands at an attractive 4x compared to the market's 9x. Despite earnings declining annually by 15.7% over five years, last year's earnings surged by an impressive 2501.2%.

SEHK:1558 Earnings and Revenue Growth as at Aug 2024
SEHK:1558 Earnings and Revenue Growth as at Aug 2024

Scholar Education Group

Simply Wall St Value Rating: ★★★★★★

Overview: Scholar Education Group, an investment holding company, provides K-12 after-school education services in the People’s Republic of China and has a market cap of HK$2.73 billion.